Pfizer vaccine

Pfizer vaccine. | EFE

ReutersMadrid07/05/2021 11:05
TW
0

The Spanish government on Thursday said a U.S. proposal to waive patents on coronavirus vaccines signals the "way forward" but will not be enough to guarantee supplies to developing countries.

Approving such a suspension of intellectual property rights would take time and, in the meantime, pharmaceutical companies should be flexible in granting voluntary licences, it said in a working paper entitled Vaccines for All.

Related news
Restaurant in Mallorca during the pandemic

Pandemic compensation claims by Mallorcan companies rejected by Spain's Supreme Court

More related news

The paper, which Spain's Prime Minister Pedro Sanchez is due to present on Friday at a European Union summit in Porto, calls for the removal of trade barriers and logistical hurdles to reduce a global shortfall in vaccine production.

"Unequal access to vaccines between developed and developing countries is not only at the core of a feeling of injustice, but also poses a health risk for the world," the paper read.
Spain also proposed a platform to monitor global vaccine manufacturing sites and match idle production capacity with demand.

Taking advantage of a slowdown in global air transport, the paper suggests airlines should work with international organisations to play a greater role in vaccine distribution.